Literature DB >> 7037866

Selected cardiac and metabolic responses to pseudoephedrine with exercise.

T P Bright, B W Sandage, H P Fletcher.   

Abstract

Pseudoephedrine hydrochloride was evaluated at two dosage levels in six normal healthy males, at rest and during submaximal exercise. Although there appeared to be a dose-related rise and during submaximal exercise. Although there appeared to be a dose-related rise in resting heart rate, it was not statistically significant. The drug had no effect on the amount of time required to reach 85 per cent maximal predicted heart rates while on the treadmill or on the amount of time required to recover baseline heart rates. Also, there was no drug effect observed on blood pressure at rest, during exercise, or in the recovery period. There was a significant increase in the frequency of sinus arrhythmias after the 120-mg pseudoephedrine dose. There appeared to be no drug effect on postexercise blood glucose and insulin levels.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7037866     DOI: 10.1002/j.1552-4604.1981.tb05655.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  10 in total

Review 1.  Athletes and doping: effects of drugs on the respiratory system.

Authors:  P N Dekhuijzen; H A Machiels; L M Heunks; H F van der Heijden; R H van Balkom
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

2.  Elimination of ephedrines in urine following multiple dosing: the consequences for athletes, in relation to doping control.

Authors:  Neil Chester; David R Mottram; Thomas Reilly; Mark Powell
Journal:  Br J Clin Pharmacol       Date:  2004-01       Impact factor: 4.335

3.  Ephedra and its application to sport performance: another concern for the athletic trainer?

Authors:  M E Powers
Journal:  J Athl Train       Date:  2001-10       Impact factor: 2.860

Review 4.  The rush to adrenaline: drugs in sport acting on the beta-adrenergic system.

Authors:  E Davis; R Loiacono; R J Summers
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

Review 5.  Subtypes of functional alpha1-adrenoceptor.

Authors:  James R Docherty
Journal:  Cell Mol Life Sci       Date:  2009-10-28       Impact factor: 9.261

Review 6.  Drugs and sport. Research findings and limitations.

Authors:  P M Clarkson; H S Thompson
Journal:  Sports Med       Date:  1997-12       Impact factor: 11.136

7.  Drugs, athletes, and family physicians. When to withhold medications and when to document prescriptions.

Authors:  R Olson
Journal:  Can Fam Physician       Date:  1996-10       Impact factor: 3.275

Review 8.  Non-prescription sympathomimetic agents and hypertension.

Authors:  S S Chua; S I Benrimoj
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Sep-Oct

Review 9.  Caffeine and ephedrine: physiological, metabolic and performance-enhancing effects.

Authors:  Faidon Magkos; Stavros A Kavouras
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

Review 10.  Effects of pseudoephedrine on parameters affecting exercise performance: a meta-analysis.

Authors:  Maria D Gheorghiev; Farzad Hosseini; Jason Moran; Chris E Cooper
Journal:  Sports Med Open       Date:  2018-10-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.